BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30049200)

  • 21. Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa.
    Renzi A; De Bonis P; Morandi L; Lenzi J; Tinto D; Rigillo A; Bettini G; Bellei E; Sabattini S
    PLoS One; 2019; 14(4):e0215621. PubMed ID: 30998743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran.
    Seifi S; Shafaei SN; Nosrati K; Ariaeifar B
    Asian Pac J Cancer Prev; 2009; 10(4):661-4. PubMed ID: 19827890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
    Kushner J; Bradley G; Jordan RC
    J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.
    Cruz I; Snijders PJ; Van Houten V; Vosjan M; Van der Waal I; Meijer CJ
    J Clin Pathol; 2002 Nov; 55(11):834-40. PubMed ID: 12401821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study.
    Yan JJ; Tzeng CC; Jin YT
    J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CDK6 in Oral Squamous Cell Carcinomas.
    Andisheh-Tadbir A; Ashraf MJ; Jeiroodi N
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1013-1016. PubMed ID: 29693970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
    Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
    Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemically Detection of Angiogenesis in Oral Pre-Cancerous Lesions Compared with Oral Invasive Carcinomas.
    Kargahi N; Torabinia N; Razavi SM; Tahririan D; Kamani H; Nazari M
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1805-1808. PubMed ID: 30049191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
    Girod SC; Kühnast T; Ulrich S; Krueger GR
    In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral squamous cell carcinoma from users and nonusers of tobacco and alcohol: clinicopathologic features and immunoreactivity of VEGF, caspase-3, and p53.
    Scheidt JH; Yurgel LS; Romanini J; Cherubini K; de Figueiredo MA; Salum FG
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):148-53. PubMed ID: 22595944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa.
    Simionescu C; Mărgăritescu C; Georgescu CV; Surpăţeanu M
    Rom J Morphol Embryol; 2005; 46(2):155-9. PubMed ID: 16287003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
    Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
    J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
    van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
    Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
    Ichikawa M; Ishii K; Nakajima T; Mogi K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
    Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of P53 gene expression by immunohistochemistry to diagnosis oral precancerous lesions.
    Wang L; Qi F; Hao L; Sun H
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):158-162. PubMed ID: 34933716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas.
    Kudo Y; Takata T; Ogawa I; Sato S; Nikai H
    Oncol Rep; 1999; 6(3):539-45. PubMed ID: 10203588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.